SARTORELLO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.943
AS - Asia 584
EU - Europa 428
SA - Sud America 156
AF - Africa 113
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.237
Nazione #
US - Stati Uniti d'America 1.890
SG - Singapore 199
CN - Cina 142
BR - Brasile 107
HK - Hong Kong 74
VN - Vietnam 73
FI - Finlandia 53
DE - Germania 50
IT - Italia 45
GB - Regno Unito 40
SE - Svezia 40
PL - Polonia 23
FR - Francia 21
NL - Olanda 18
RU - Federazione Russa 17
UA - Ucraina 16
EC - Ecuador 13
TR - Turchia 11
ZA - Sudafrica 11
AT - Austria 10
CI - Costa d'Avorio 10
CA - Canada 9
BY - Bielorussia 8
ES - Italia 8
CO - Colombia 7
IE - Irlanda 7
MG - Madagascar 7
MX - Messico 7
PE - Perù 7
AR - Argentina 6
BD - Bangladesh 6
BE - Belgio 6
IN - India 6
LA - Repubblica Popolare Democratica del Laos 6
PK - Pakistan 6
HR - Croazia 5
HU - Ungheria 5
ME - Montenegro 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
YT - Mayotte 5
ZW - Zimbabwe 5
AZ - Azerbaigian 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EE - Estonia 4
GA - Gabon 4
GM - Gambi 4
IR - Iran 4
IS - Islanda 4
JM - Giamaica 4
JO - Giordania 4
JP - Giappone 4
KR - Corea 4
LC - Santa Lucia 4
MA - Marocco 4
NI - Nicaragua 4
PT - Portogallo 4
RE - Reunion 4
SN - Senegal 4
AL - Albania 3
BF - Burkina Faso 3
BG - Bulgaria 3
BO - Bolivia 3
BZ - Belize 3
CL - Cile 3
CR - Costa Rica 3
CV - Capo Verde 3
CY - Cipro 3
DJ - Gibuti 3
EG - Egitto 3
IL - Israele 3
IQ - Iraq 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
MR - Mauritania 3
MW - Malawi 3
NO - Norvegia 3
PH - Filippine 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
SO - Somalia 3
UG - Uganda 3
VE - Venezuela 3
AD - Andorra 2
AI - Anguilla 2
AM - Armenia 2
AU - Australia 2
BS - Bahamas 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
DZ - Algeria 2
HN - Honduras 2
HT - Haiti 2
KE - Kenya 2
KZ - Kazakistan 2
Totale 3.175
Città #
Fairfield 307
Ashburn 225
Chandler 154
Houston 128
Singapore 123
Cambridge 115
Woodbridge 114
Seattle 104
Ann Arbor 84
Wilmington 76
Hong Kong 72
Jacksonville 57
Dong Ket 50
Princeton 40
Santa Clara 38
Boardman 35
Beijing 30
San Diego 25
Los Angeles 20
Munich 18
Bytom 17
Nanjing 17
Medford 16
Helsinki 15
Washington 15
New York 14
Padova 12
Roxbury 12
Buffalo 11
Turku 11
Abidjan 10
São Paulo 9
Changsha 8
Hefei 8
Dallas 7
Des Moines 7
Ho Chi Minh City 7
Minsk 7
Shenyang 7
Antananarivo 6
Dublin 6
Hanoi 6
Hebei 6
Johannesburg 6
London 6
Vientiane 6
Guayaquil 5
Harare 5
Vienna 5
Amman 4
Banjul 4
Borås 4
Chicago 4
Dakar 4
Istanbul 4
Libreville 4
Madrid 4
Managua 4
Milan 4
Norwalk 4
Nuremberg 4
Padua 4
Tallinn 4
Tunis 4
Villafranca Padovana 4
Waanrode 4
Warsaw 4
Baku 3
Brooklyn 3
Castries 3
Chennai 3
Council Bluffs 3
Curitiba 3
Djibouti 3
Florence 3
Frankfurt am Main 3
Kampala 3
Kharkiv 3
Lima 3
Nouakchott 3
Phnom Penh 3
Podgorica 3
Redondo Beach 3
Redwood City 3
Reykjavik 3
Stockholm 3
Tel Aviv 3
Tianjin 3
Tivoli 3
Zurich 3
Andorra la Vella 2
Antakya 2
Asunción 2
Atlanta 2
Bamako 2
Belize City 2
Belo Horizonte 2
Bishkek 2
Blantyre 2
Boston 2
Totale 2.243
Nome #
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 205
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 171
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 156
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 156
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 152
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 146
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 140
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 132
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 129
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 124
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 124
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 118
Which assay is the most suitable to investigate von Willebrand factor functional activity? 117
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 114
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 110
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 110
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 108
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 108
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 107
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 107
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 105
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 104
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 97
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 88
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 85
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 82
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 63
Totale 3.258
Categoria #
all - tutte 12.098
article - articoli 11.808
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 4 32 12 30 13 28 37 17 26 75
2021/2022364 16 29 70 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025664 1 50 42 36 91 26 30 33 53 24 116 162
2025/2026642 134 212 296 0 0 0 0 0 0 0 0 0
Totale 3.258